Institut Pasteur de Tunis - معهد باستور تونس

Name

Institut Pasteur de Tunis - معهد باستور تونس

Legal name

Institut Pasteur de Tunis

Website

https://pasteur.tn

Company type

Public

Founded year

1893

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Public Health Research and Diagnostic Services

NAICS

Scientific Research and Development Services (5417), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

National/State/Local Immunization Program Offices (HLAJAHAA)

akta.pro secondary industries

Immunization & Vaccine Delivery Programs (BPADAIAB), Infectious Disease & Pandemic Preparedness Vaccines (emerging pathogens) (HLAAAEAC), Travel & Tropical Disease Vaccines (HLAIAEAE)

Keywords

• Biomedical research services
• Vaccine production
• Public health diagnostics
• Infectious disease research
• Rabies prophylaxis services

Headquarters

HQ city

Tunis

HQ country

Tunisia

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Public Health Services: The institute operates as a government-funded public scientific research establishment under the Ministry of Health (Law 58-35), providing vaccination services, biomedical analyses, and public health prophylaxis services.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Institut Pasteur de Tunis is a public scientific research establishment that produces BCG vaccines and therapeutic serums, performs biomedical diagnostic analyses, and delivers vaccination and rabies prophylaxis services to citizens and travelers. It also conducts infectious disease research across ten specialized laboratories and provides higher education and clinical research training including through the TDR Regional Training Centre.

Product overview

Institut Pasteur de Tunis operates as a unified public research institution under the Ministry of Health, offering a portfolio of products and services including vaccine production (BCG vaccines for intradermal use and bladder cancer immunotherapy), therapeutic serums, and biomedical diagnostic analyses. The institution provides public health services such as international vaccinations, rabies prophylaxis, and travel health consultations. Its research infrastructure comprises ten specialized laboratories and the IPT-OMICS high-throughput platform for genomics, proteomics, and bioinformatics research. The institution also operates a Regional Training Centre for quality assurance and clinical research training.

Differentiator

Problem solved

Functional benefit

Products and services

• Vaccins BCG (BCG Vaccines) BCG intradermal vaccine and fresh BCG vaccine for bladder cancer immunotherapy, produced by Institut Pasteur de Tunis for national health needs and distributed to domestic healthcare providers.
• Sérums thérapeutiques (Therapeutic Serums) Therapeutic serums produced by Institut Pasteur de Tunis for domestic healthcare requirements, manufactured by the dedicated Unité de production des sérums thérapeutiques.
• Analyses Biomédicales (Biomedical Analyses) Comprehensive guide and delivery of biomedical analyses across multiple services of Institut Pasteur de Tunis, available to citizens and healthcare providers.
• Vaccinations Internationales (International Vaccinations) International vaccination services including yellow fever, rabies, hepatitis A/B, typhoid, meningitis, MMR, pneumococcal, and polio vaccines, with pre-travel consultations and International Vaccination Certificates issued per dose.
• Prophylaxie antirabique (Rabies Prophylaxis) Rabies prophylaxis services including vaccination and medical consultation provided by the laboratoire de la rage at Institut Pasteur de Tunis to citizens and travelers.
• IPT-OMICS Platform High-throughput technology platform providing genomics, proteomics, imaging, and preliminary bioinformatics analyses to public and private research teams.
• Laboratoires de Recherche (Research Laboratories) Ten specialized research laboratories covering a wide range of national health priorities in infectious diseases, supported by government and international funding.
• TDR Regional Training Centre Regional training centre focused on quality assurance, good clinical/laboratory practices (GCP, GCLP), ethics and human protection in research, and implementation research using the TDR toolkit and GHRP course, serving countries in the Eastern Mediterranean Region.

Quantifiable outcome

• 210,000+ biomedical analyses performed annually
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• TDR (Special Programme for Research and Training in Tropical Diseases)coreStrategic or Co-development PartnerThe TDR Regional Training Centre at Institut Pasteur de Tunis focuses on promotion of quality assurance and good practices (GCP, GCLP), ethics and human protection in research, and implementation research using the TDR toolkit and GHRP course. This partnership serves countries in the Eastern Mediterranean Region.
• Université de Tunis El ManarcoreStrategic or Co-development PartnerThe institute interacts with boards of the Université de Tunis El Manar and Doctoral schools at the Faculté des Sciences and Faculté de Médecine in Tunis for managing clinical research training of undergraduate, MD, MVD, MSc, and PhD students and post-doctoral students.
• Ministère de la Santé (Ministry of Health)coreOthersThe institute is placed under the oversight (tutelle) of the Ministry of Health and assumes missions defined by Law 58-35, which defines it as an establishment of scientific research using Pasteurian methods.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Institut Pasteur de Dakar: Senegal-based Pasteur network institute that combines vaccine manufacturing (including yellow fever), biomedical research, public-health services, and training — almost identical operating model to IPT and a direct regional comparable.
• Institut Pasteur: Paris-headquartered founding member of the global Pasteur network; operates the same combination of research, vaccine production, biomedical analyses, and training under a public-health mandate — the closest organisational analogue to IPT.
• Institut Pasteur de Lille: French Pasteur network member focused on biomedical research, public-health studies, and training; comparable to IPT on the research-and-training axis, though smaller on vaccine manufacturing.
• Institut Pasteur de la Guyane: French overseas-terry Pasteur network member focused on tropical infectious disease research, biomedical analyses, and public-health services; comparable to IPT on tropical-medicine and laboratory-services activities.
• Institut Pasteur du Cambodge: Cambodia-based Pasteur network member combining biomedical research, public-health surveillance, and training; structurally analogous to IPT as a Pasteur-institute operating in a developing-country setting.
• Centre Pasteur du Cameroun: Cameroon-based Pasteur network institute providing biomedical analyses, vaccination, and public-health research — directly comparable operating model to IPT in an African context.
• Institut Pasteur de la Guadeloupe: Caribbean-based Pasteur network institute combining biomedical analyses, vaccination, and infectious-disease research; another Pasteur-network comparable on the laboratory-and-vaccination axis.
• Institut Pasteur de Madagascar: Madagascar-based Pasteur network member combining biomedical research, vaccine and biological production, and public-health services — structurally comparable to IPT and another reference point for African Pasteur-institute scale.

Regional players

• Institut Pasteur du Maroc: Morocco-based Pasteur network institute with a similar portfolio of vaccines, biomedical analyses, and research; operates in a neighbouring North African country with a closely comparable regulatory and epidemiological context to IPT.
• Institut Pasteur d'Algérie: Algerian Pasteur network institute engaged in vaccine production, biological diagnostics, and research; a North African counterpart with a near-identical mix of public-health, manufacturing, and laboratory activities to IPT.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xtwitter.com/InstitutPasteurDeTunis
• YouTubeyoutube.com/watch?v=4P-wwGx6Hy0
• Facebookfacebook.com/InstitutPasteurDeTunis
• LinkedInlinkedin.com/company/institut-pasteur-de-tunis---

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institut Pasteur de Tunis - معهد باستور تونس